In unilateral intermittent exotropia, distance control improved significantly over 3 months of therapy (mean 2.9 to 1.7; ...
Bionano Genomics, Inc. (Nasdaq: BNGO) today reported financial results for the fourth quarter and full year ended December 31, 2025. "2025 demonstrated the momentum we built as a business,” commented ...
A New National Running Movement to Support Kids with Brain Cancer Kids with brain cancer don’t get to choose their ...
Explore high-paying careers for neurodivergent professionals and actionable tips to land roles that value focus, creativity ...
Hyperfine, Inc. (NASDAQ:HYPR) Q4 2025 Earnings Call Transcript March 18, 2026 Hyperfine, Inc. beats earnings expectations.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results